Work

TSLP AND IL-13 Dual Blockade By Lunsekimig Provides Broader Benefits On Type-2 Inflammation

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa4861

Authors: Yui-Hsi Wang, Hamid Mattoo, Joo-Hye Song, Michael Bursilovsky, Mark Swistak, Keith Graver, Winne Tung, Hongwei Han, Sigrid Cornelis, Paul Bryce, Arun Subramaniam, Frank Nestle, John Bertin, Alexandra Hicks, Ravi Ramadas

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404091397

Cites:

Cited by: 3

Related to: 10